InsiderClue
Insiders · Profile

Keyes Jason A

Chief Financial Officer at BlossomHill Therapeutics · Chief Financial Officer at Equillium. Filing since 1 Aug 2019. CIK 0001678152

BLSM BlossomHill Therapeutics, Inc. Chief Financial Officer · 1 trade EQ Equillium, Inc. Chief Financial Officer · 16 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BLSM BlossomHill Therapeutics, Inc.
10 Aug 2026
Chief Financial Officer
Bought
700
$11.20K
opened
EQ Equillium, Inc.
23 Jan 2025
Chief Financial Officer
Sold on a plan
10,000
$6.50K
21.0%
EQ Equillium, Inc.
14 Nov 2024
Chief Financial Officer
Sold on a plan
10,000
$7.00K
17.3%
EQ Equillium, Inc.
26 Sep 2024
Chief Financial Officer
Sold on a plan
10,000
$8.10K
14.8%
EQ Equillium, Inc.
16 Jul 2024
Chief Financial Officer
Sold on a plan
10,000
$8.70K
12.9%
EQ Equillium, Inc.
29 Aug 2022
Chief Financial Officer
Sold, plan not stated
7,000
$19.81K
8.3%
EQ Equillium, Inc.
6 Jun 2022
Chief Financial Officer
Sold, plan not stated
5,000
$12.60K
5.6%
EQ Equillium, Inc.
4 Apr 2022
Chief Financial Officer
Sold, plan not stated
8,000
$25.44K
8.2%
EQ Equillium, Inc.
1 Dec 2021
Chief Financial Officer
Sold, plan not stated
5,000
$25.40K
4.9%
EQ Equillium, Inc.
27 Sep 2021
Chief Financial Officer
Sold, plan not stated
8,000
$53.92K
7.2%
EQ Equillium, Inc.
27 Jul 2021
Chief Financial Officer
Sold, plan not stated
5,000
$28.59K
4.3%
EQ Equillium, Inc.
26 May 2021
Chief Financial Officer
Sold, plan not stated
5,000
$32.48K
4.1%
EQ Equillium, Inc.
23 Dec 2020
Chief Financial Officer
Sold, plan not stated
8,000
$37.91K
6.2%
EQ Equillium, Inc.
18 Feb 2020
Chief Financial Officer
Sold, plan not stated
5,000
$25.14K
3.7%
EQ Equillium, Inc.
21 Jan 2020
Chief Financial Officer
Sold, plan not stated
5,000
$22.04K
3.6%
EQ Equillium, Inc.
3 Sep 2019
Chief Financial Officer
Sold, plan not stated
5,000
$17.98K
3.5%
EQ Equillium, Inc.
1 Aug 2019
Chief Financial Officer
Sold, plan not stated
5,000
$19.94K
3.4%
17 decisions on file.